Trials / Completed
CompletedNCT01195831
Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
Multicentre, Randomized, Investigator-Blinded, Parallel-group Study to Assess the Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 244 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the clinical efficacy of once daily treatment for 4 weeks with Xamiol® gel (calcipotriol plus betamethasone) with twice daily treatment for 4 weeks with Calcipotriol Scalp Solution in patients with scalp psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xamiol® gel | Once daily application |
| DRUG | Calcipotriol scalp solution | Twice daily application |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-09-06
- Last updated
- 2025-03-12
- Results posted
- 2012-04-19
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01195831. Inclusion in this directory is not an endorsement.